Bausch Health Companies Inc. Cost of Goods Sold (Deprecated 2018-01-31)
Bausch Health Companies Inc. (BHC) reported Cost of Goods Sold (Deprecated 2018-01-31) of $584.00 million for the 3-month period ending 2018-06-30, per its 10-Q filed 2018-08-07.
Discontinued › Expense Statement › Cost of Sales
us-gaap:CostOfGoodsSold · last filed 2018-08-10
- Bausch Health Companies Inc. cost of goods sold (deprecated 2018-01-31) for the quarter ending 2018-06-30 was $584.00M, a 8.03% decline year-over-year.
- Bausch Health Companies Inc. cost of goods sold (deprecated 2018-01-31) for the quarter ending 2018-03-31 was $560.00M, a 4.11% decline year-over-year.
- Bausch Health Companies Inc. cost of goods sold (deprecated 2018-01-31) for the quarter ending 2017-12-31 was $637.00M, a 2.75% decline year-over-year.
- Bausch Health Companies Inc. cost of goods sold (deprecated 2018-01-31) for the quarter ending 2017-09-30 was $650.00M, a 0.15% increase year-over-year.
- Bausch Health Companies Inc. cost of goods sold (deprecated 2018-01-31) for fiscal 2014 was $2.18B, a 17.97% increase from fiscal 2013.
- Bausch Health Companies Inc. cost of goods sold (deprecated 2018-01-31) for fiscal 2013 was $1.85B, a 103.99% increase from fiscal 2012.
- Bausch Health Companies Inc. cost of goods sold (deprecated 2018-01-31) for fiscal 2012 was $905.10M, a 32.37% increase from fiscal 2011.
- Bausch Health Companies Inc. cost of goods sold (deprecated 2018-01-31) for fiscal 2011 was $683.75M, a 72.84% increase from fiscal 2010.
| Period end | Cost of Goods Sold (Deprecated 2018-01-31) 3 month | Cost of Goods Sold (Deprecated 2018-01-31) 3 month as first filed | Cost of Goods Sold (Deprecated 2018-01-31) 6 month | Cost of Goods Sold (Deprecated 2018-01-31) 6 month as first filed | Cost of Goods Sold (Deprecated 2018-01-31) 9 month | Cost of Goods Sold (Deprecated 2018-01-31) 9 month as first filed | Cost of Goods Sold (Deprecated 2018-01-31) 12 month | Cost of Goods Sold (Deprecated 2018-01-31) 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2018-06-30 | $584.00M 10-Q · filed 2018-08-07 | $1.14B 10-Q · filed 2018-08-07 | $1.78B derived: sum of 3 quarters · filed 2018-08-10 | $2.43B derived: sum of 4 quarters · filed 2018-08-10 | ||||
| 2018-03-31 | $560.00M 10-Q · filed 2018-05-08 | $1.20B derived: sum of 2 quarters · filed 2018-08-10 | $1.85B derived: sum of 3 quarters · filed 2018-08-10 | $2.48B derived: sum of 4 quarters · filed 2018-08-10 | ||||
| 2017-12-31 | $637.00M derived: 8-K 12 month − 10-Q 9 month · filed 2018-08-10 | $1.29B derived: sum of 2 quarters · filed 2018-08-10 | $1.92B derived: sum of 3 quarters · filed 2018-08-10 | $2.51B 8-K · filed 2018-08-10 | ||||
| 2017-09-30 | $650.00M 10-Q · filed 2017-11-07 | $1.28B derived: sum of 2 quarters · filed 2018-08-07 | $1.87B 10-Q · filed 2017-11-07 | $2.52B derived: sum of 4 quarters · filed 2018-08-10 | ||||
| 2017-06-30 | $635.00M 10-Q · filed 2018-08-07 | $1.22B 10-Q · filed 2018-08-07 | $1.87B derived: sum of 3 quarters · filed 2018-08-10 | $2.52B derived: sum of 4 quarters · filed 2018-08-10 | ||||
| 2017-03-31 | $584.00M 10-Q · filed 2018-05-08 | $1.24B derived: sum of 2 quarters · filed 2018-08-10 | $1.89B derived: sum of 3 quarters · filed 2018-08-10 | $2.54B derived: sum of 4 quarters · filed 2018-08-10 | ||||
| 2016-12-31 | $655.00M derived: 8-K 12 month − 10-Q 9 month · filed 2018-08-10 | $1.30B derived: sum of 2 quarters · filed 2018-08-10 | $1.95B derived: sum of 3 quarters · filed 2018-08-10 | $2.57B 8-K · filed 2018-08-10 | ||||
| 2016-09-30 | $649.00M 10-Q · filed 2017-11-07 | $649.20M 10-Q · filed 2016-11-09 | $1.30B derived: sum of 2 quarters · filed 2017-11-07 | $1.92B 10-Q · filed 2017-11-07 | $1.92B 10-Q · filed 2016-11-09 | $2.64B derived: sum of 4 quarters · filed 2018-08-10 | ||
| 2016-06-30 | $648.00M 10-Q · filed 2017-08-08 | $647.30M 10-Q · filed 2016-08-09 | $1.27B 10-Q · filed 2017-08-08 | $1.27B 10-Q · filed 2016-08-09 | $1.99B derived: sum of 3 quarters · filed 2018-08-10 | $2.62B derived: sum of 4 quarters · filed 2018-08-10 | ||
| 2016-03-31 | $620.00M 10-Q · filed 2017-05-09 | $620.20M 10-Q · filed 2016-06-07 | $1.34B derived: sum of 2 quarters · filed 2018-08-10 | $1.97B derived: sum of 3 quarters · filed 2018-08-10 | $2.64B derived: sum of 4 quarters · filed 2018-08-10 | |||
| 2015-12-31 | $719.60M derived: 8-K 12 month − 10-Q 9 month · filed 2018-08-10 | $1.35B derived: sum of 2 quarters · filed 2018-08-10 | $2.02B derived: sum of 3 quarters · filed 2018-08-10 | $2.53B 8-K · filed 2018-08-10 | $2.53B 10-K · filed 2016-04-29 | |||
| 2015-09-30 | $634.60M 10-Q · filed 2016-11-09 | $1.30B derived: sum of 2 quarters · filed 2016-11-09 | $1.81B 10-Q · filed 2016-11-09 | $1.86B 10-Q · filed 2015-10-26 | $2.37B derived: sum of 4 quarters · filed 2017-03-01 | |||
| 2015-06-30 | $669.90M 10-Q · filed 2016-08-09 | $1.18B 10-Q · filed 2016-08-09 | $1.23B 10-Q · filed 2015-07-28 | $1.74B derived: sum of 3 quarters · filed 2017-03-01 | $2.28B derived: sum of 4 quarters · filed 2017-03-01 | |||
| 2015-03-31 | $507.90M 10-Q · filed 2016-06-07 | $560.40M 10-Q · filed 2015-04-30 | $1.07B derived: sum of 2 quarters · filed 2017-03-01 | $1.61B derived: sum of 3 quarters · filed 2017-03-01 | $2.18B derived: sum of 4 quarters · filed 2017-03-01 | |||
| 2014-12-31 | $558.50M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-01 | $1.10B derived: sum of 2 quarters · filed 2017-03-01 | $1.67B derived: sum of 3 quarters · filed 2017-03-01 | $2.18B 10-K · filed 2017-03-01 | $2.20B 10-K · filed 2015-02-25 | |||
| 2014-09-30 | $545.80M 10-Q · filed 2015-10-26 | $1.12B derived: sum of 2 quarters · filed 2015-10-26 | $1.62B 10-Q · filed 2015-10-26 | $2.34B derived: sum of 4 quarters · filed 2016-04-29 | ||||
| 2014-06-30 | $569.60M 10-Q · filed 2015-07-28 | $1.07B 10-Q · filed 2015-07-28 | $1.79B derived: sum of 3 quarters · filed 2016-04-29 | $2.35B derived: sum of 4 quarters · filed 2016-04-29 | ||||
| 2014-03-31 | $504.10M 10-Q · filed 2015-04-30 | $1.22B derived: sum of 2 quarters · filed 2016-04-29 | $1.78B derived: sum of 3 quarters · filed 2016-04-29 | $2.07B derived: sum of 4 quarters · filed 2016-04-29 | ||||
| 2013-12-31 | $717.40M derived: 10-K 12 month − 10-Q 9 month · filed 2016-04-29 | $1.28B derived: sum of 2 quarters · filed 2016-04-29 | $1.56B derived: sum of 3 quarters · filed 2016-04-29 | $1.85B 10-K · filed 2016-04-29 | $1.85B 10-K · filed 2014-02-28 | |||
| 2013-09-30 | $560.80M 10-Q · filed 2014-10-24 | $560.86M 10-Q · filed 2013-11-01 | $844.00M derived: sum of 2 quarters · filed 2014-10-24 | $1.13B 10-Q · filed 2014-10-24 | $1.13B 10-Q · filed 2013-11-01 | $1.40B derived: sum of 4 quarters · filed 2015-02-25 | ||
| 2013-06-30 | $283.20M 10-Q · filed 2014-08-01 | $283.18M 10-Q · filed 2013-08-07 | $568.10M 10-Q · filed 2014-08-01 | $568.09M 10-Q · filed 2013-08-07 | $839.58M derived: sum of 3 quarters · filed 2015-02-25 | $1.06B derived: sum of 4 quarters · filed 2015-02-25 | ||
| 2013-03-31 | $284.90M 10-Q · filed 2014-05-09 | $284.90M 10-Q · filed 2013-05-03 | $556.38M derived: sum of 2 quarters · filed 2015-02-25 | $772.88M derived: sum of 3 quarters · filed 2015-02-25 | $965.80M derived: sum of 4 quarters · filed 2015-02-25 | |||
| 2012-12-31 | $271.48M derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-25 | $487.98M derived: sum of 2 quarters · filed 2015-02-25 | $680.90M derived: sum of 3 quarters · filed 2015-02-25 | $905.10M 10-K · filed 2015-02-25 | $921.53M 10-K · filed 2013-02-28 | |||
| 2012-09-30 | $216.49M 10-Q · filed 2013-11-01 | $219.67M 10-Q · filed 2012-11-05 | $409.42M derived: sum of 2 quarters · filed 2013-11-01 | $633.62M 10-Q · filed 2013-11-01 | $646.39M 10-Q · filed 2012-11-05 | $815.60M derived: sum of 4 quarters · filed 2014-02-28 | ||
| 2012-06-30 | $192.93M 10-Q · filed 2013-08-07 | $197.28M 10-Q · filed 2012-08-03 | $417.12M 10-Q · filed 2013-08-07 | $426.73M 10-Q · filed 2012-08-03 | $599.11M derived: sum of 3 quarters · filed 2014-02-28 | $761.67M derived: sum of 4 quarters · filed 2014-02-28 | ||
| 2012-03-31 | $224.20M 10-Q · filed 2013-05-03 | $238.81M 10-Q · filed 2012-05-04 | $406.18M derived: sum of 2 quarters · filed 2014-02-28 | $568.75M derived: sum of 3 quarters · filed 2014-02-28 | $738.66M derived: sum of 4 quarters · filed 2014-02-28 | |||
| 2011-12-31 | $181.98M derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-28 | $344.55M derived: sum of 2 quarters · filed 2014-02-28 | $514.46M derived: sum of 3 quarters · filed 2014-02-28 | $683.75M 10-K · filed 2014-02-28 | ||||
| 2011-09-30 | $162.57M 10-Q · filed 2012-11-05 | $332.48M derived: sum of 2 quarters · filed 2012-11-05 | $501.77M 10-Q · filed 2012-11-05 | $712.41M derived: sum of 4 quarters · filed 2013-02-28 | ||||
| 2011-06-30 | $169.91M 10-Q · filed 2012-08-03 | $339.20M 10-Q · filed 2012-08-03 | $549.85M derived: sum of 3 quarters · filed 2013-02-28 | $611.99M derived: sum of 4 quarters · filed 2013-02-28 | ||||
| 2011-03-31 | $169.29M 10-Q · filed 2012-05-04 | $379.94M derived: sum of 2 quarters · filed 2013-02-28 | $442.08M derived: sum of 3 quarters · filed 2013-02-28 | $505.93M derived: sum of 4 quarters · filed 2013-02-28 | ||||
| 2010-12-31 | $210.65M derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-28 | $272.79M derived: sum of 2 quarters · filed 2013-02-28 | $336.64M derived: sum of 3 quarters · filed 2013-02-28 | $395.60M 10-K · filed 2013-02-28 | ||||
| 2010-09-30 | $62.14M 10-Q · filed 2011-11-04 | $125.99M derived: sum of 2 quarters · filed 2011-11-04 | $184.95M 10-Q · filed 2011-11-04 | $243.69M derived: sum of 4 quarters · filed 2012-02-29 | ||||
| 2010-06-30 | $63.85M 10-Q · filed 2011-08-08 | $122.81M 10-Q · filed 2011-08-08 | $181.55M derived: sum of 3 quarters · filed 2012-02-29 | $232.22M derived: sum of 4 quarters · filed 2012-02-29 | ||||
| 2010-03-31 | $58.95M 10-Q · filed 2011-05-10 | $117.70M derived: sum of 2 quarters · filed 2012-02-29 | $168.37M derived: sum of 3 quarters · filed 2012-02-29 | $218.42M derived: sum of 4 quarters · filed 2012-02-29 | ||||
| 2009-12-31 | $58.74M derived: 10-K 12 month − 10-Q 9 month · filed 2012-02-29 | $109.41M derived: sum of 2 quarters · filed 2012-02-29 | $159.47M derived: sum of 3 quarters · filed 2012-02-29 | $204.31M 10-K · filed 2012-02-29 | ||||
| 2009-09-30 | $50.67M 10-Q · filed 2010-11-05 | $100.73M derived: sum of 2 quarters · filed 2010-11-05 | $145.57M 10-Q · filed 2010-11-05 | |||||
| 2009-06-30 | $50.06M 10-Q · filed 2010-08-06 | $94.90M 10-Q · filed 2010-08-06 | ||||||
| 2008-12-31 | $197.17M 10-K · filed 2011-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Braveheart Bio, Inc. (BRVE) | United States | $2.106B | |
| PALVELLA THERAPEUTICS, INC. (PVLA) | United States | $2.105B | -35.55 |
| Trevi Therapeutics, Inc. (TRVI) | United States | $2.091B | -51.93 |
| OCULAR THERAPEUTIX, INC (OCUL) | United States | $2.159B | -7.15 |
| Prestige Consumer Healthcare Inc. (PBH) | United States | $2.163B | 13.03 |
| Generate Biomedicines, Inc. (GENB) | United States | $2.052B | |
| PERRIGO Co plc (PRGO) | Ireland | $2.038B | -0.79 |
| NEKTAR THERAPEUTICS (NKTR) | United States | $2.026B | -9.05 |
| Aurinia Pharmaceuticals Inc. (AUPH) | $2.207B | 7.18 | |
| UroGen Pharma Ltd. (URGN) | $2.015B | -18.42 |